ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2021
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Ten years of Foodbook: Utilization of Foodbook survey data for research.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Article
- Impact of Balkan and Banat Donkey Milk on the Technological Process, Microbiological Quality, Composition, and Consumer Acceptability of Rolled Cheese.Foods (Basel, Switzerland) · 2025Article
- A virulent escherichia coli O121-B2-ST131 strain causes hemorrhagic pneumonia in mink: evidence from pathogenicity and animal challenge experiments.BMC veterinary research · 2025Article
- Prevalence Trends of Foodborne PathogensInternational journal of environmental research and public health · 2024Article
- Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982-2024) and food safety criteria.Gut pathogens · 2024Review
- Effects of PEF on Cell and Transcriptomic ofMicroorganisms · 2024Article
- Multidrug-resistant Shiga toxin-producing Escherichia coli and hybrid pathogenic strains of bovine origin.Veterinary research communications · 2023Article
- Mild Heat Treatment and Biopreservatives for Artisanal Raw Milk Cheeses: Reducing Microbial Spoilage and Extending Shelf-Life through Thermisation, Plant Extracts and Lactic Acid Bacteria.Foods (Basel, Switzerland) · 2023Review
- Extending the Shelf Life of Raw Milk and Pasteurized Milk with Plantaricin FB-2.Foods (Basel, Switzerland) · 2023Article
- Milk-borne diseases through the lens of one health.Frontiers in microbiology · 2023Review
- Comparative genomic and phenotypic analyses of the virulence potential in Shiga toxin-producingFrontiers in cellular and infection microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2018, a Shiga toxin-producing
objectivesTo describe the
methodsCases of
resultsFour out of the seven cases consumed the same raw milk Gouda-like cheese between August and October 2018. The implicated cheese was aged longer than the required minimum of 60 days, and no production deficiencies were noted. One sample of the implicated cheese tested positive for
conclusionRaw milk Gouda and Gouda-like cheese has been implicated in three previous Shiga toxin-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.